v3.25.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND SUPPLEMENTAL DISCLOSURES (Tables)
 6 Months Ended
Jun. 30, 2025
Accounting Policies [Abstract]  
SCHEDULE OF CONTRACT LIABILITIES

The following table provides information about contract liabilities from contracts with customers, including significant changes in the contract liabilities balance during the period:

 

 

   June 30, 2025   December 31, 2024 
         
Beginning balance  $134   $- 
           
Increase due to deferral of revenue   3,330    167 
Decrease due to recognition of revenue   (3,286)   (33)
           
Ending balance  $178   $134 
SCHEDULE OF CONCENTRATION RISK

 

   Six Months Ended June 30,
   2025  2024
The Company’s largest customers are presented below as a percentage of the aggregate      
       
Revenues  Two customers accounted for 11% and 15% of revenues  One customer that accounted for 52% of revenues
       
Accounts receivable  One customer that accounted for 31% of accounts receivable  No customers that accounted for greater than 10% of accounts receivable
       
The Company’s largest vendors are presented below as a percentage of the aggregate      
       
Purchases  No vendors accounted for greater than 10% of its purchases individually and in the aggregate  One vendor that accounted for 18% of its purchases individually and in the aggregate
SCHEDULE OF SUPPLEMENTAL CASH FLOW INFORMATION

Supplemental Cash Flow Information

 

 

     2025   2024 
   Six Months Ended June 30, 
   2025   2024 
         
Supplemental disclosures of cash flow information:          
Cash paid for interest  $1   $1 
Cash paid for income taxes  $3   $1 
           
Supplemental disclosure of non-cash investing and financing activities:          
Settlement of accounts receivable with non-marketable equity securities  $563   $- 
Issuance of common shares in connection with the purchase of Lyvecom   1,000    - 
Addition of contingent liability recorded in connection with the purchase of Lyvecom     600       -  
Fair value of common shares issued as payment on notes payable   -    2,777 
Fair value of common shares issued to redeem Series C preferred shares   -    656